Vivicells International Stock Analysis

VCII Stock  USD 0.0001  0.00  0.00%   
ViviCells International is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of ViviCells International stock analysis is to determine its intrinsic value, which is an estimate of what ViviCells International is worth, separate from its market price. There are two main types of ViviCells International's stock analysis: fundamental analysis and technical analysis.
The ViviCells International stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and ViviCells International's ongoing operational relationships across important fundamental and technical indicators.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ViviCells International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For more detail on how to invest in ViviCells Stock please use our How to Invest in ViviCells International guide.

ViviCells Stock Analysis Notes

The company had not issued any dividends in recent years. ViviCells International had 1:140 split on the 9th of May 2008. ViviCells International, Inc. operates as a stem cell preservation company. The company was incorporated in 1995 and is based in Evanston, Illinois. VIVICELLS INTERNATIONAL operates under UtilitiesRenewable classification in the United States and is traded on PNK Exchange. It employs 16 people. For more information please call Kenneth Wulwick at 504-241-4400 or visit https://www.vivicells.com.

ViviCells International Quarterly Total Revenue

714,695

ViviCells International Investment Alerts

ViviCells International generated a negative expected return over the last 90 days
ViviCells International has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 3.77 M. Net Loss for the year was (14.44 K) with profit before overhead, payroll, taxes, and interest of 1.71 M.
ViviCells International currently holds about 10.26 K in cash with (1.21 M) of positive cash flow from operations.
ViviCells International has a very weak financial position based on the latest SEC disclosures

ViviCells Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 46.78 K.

ViviCells Profitablity

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.46 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.46.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.01)(0.01)
Return On Capital Employed(0.01)(0.01)
Return On Assets(0.01)(0.01)
Return On Equity(0.01)(0.01)

Management Efficiency

The current Return On Tangible Assets is estimated to decrease to -0.0077. The current Return On Capital Employed is estimated to decrease to -0.0069. The ViviCells International's current Debt To Assets is estimated to increase to 0.19, while Total Assets are projected to decrease to under 4.9 M. ViviCells International's management efficiency ratios could be used to measure how well ViviCells International manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 0.01  0.01 
Tangible Book Value Per Share 0.01  0.01 
Enterprise Value Over EBITDA(949.57)(902.10)
Price Book Value Ratio 5.35  5.62 
Enterprise Value Multiple(949.57)(902.10)
Price Fair Value 5.35  5.62 
Enterprise Value3.9 MM
The operational strategies employed by ViviCells International management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Operating Margin
0.4614
Profit Margin
(0.09)
Beta
(2.70)

Technical Drivers

In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of ViviCells International, as well as the relationship between them.

ViviCells International Price Movement Analysis

Execute Study
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. ViviCells International middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for ViviCells International. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

About ViviCells Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how ViviCells International prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ViviCells shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as ViviCells International. By using and applying ViviCells Stock analysis, traders can create a robust methodology for identifying ViviCells entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.05  0.04 
Operating Profit Margin(0.02)(0.02)
Gross Profit Margin 0.32  0.29 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ViviCells International to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Valuation Now

   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Module

Complementary Tools for ViviCells Stock analysis

When running ViviCells International's price analysis, check to measure ViviCells International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ViviCells International is operating at the current time. Most of ViviCells International's value examination focuses on studying past and present price action to predict the probability of ViviCells International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ViviCells International's price. Additionally, you may evaluate how the addition of ViviCells International to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Fundamental Analysis
View fundamental data based on most recent published financial statements